FSK Stock Analysis: FS KKR Capital | NYSE
Asset Management | NYSE, USA | Market Cap: 3.333m USD | 12M Return: -19.9% | US3026352068 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 26.8M
EPS Trend: -94.3%
Qual. Beats: 0
Rev. Trend: -81.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
FS KKR Capital Corp. (NYSE: FSK) is a business development company (BDC) that provides customized credit solutions to private U.S. middle-market companies. BDCs are regulated under the Investment Company Act of 1940 and generally must distribute most of their taxable income as dividends, making them a yield-oriented vehicle within the financials sector.
The fund invests primarily in senior secured debt-chiefly first lien loans, with second lien and mezzanine loans to a lesser extent-acquired either in the secondary loan market or directly from borrowers. Debt investments are often paired with equity kickers such as warrants or options, and FSK may take minority common or preferred equity stakes alongside a debt position or via co-investment with a financial sponsor. Corporate bonds are pursued on an opportunistic basis.
FSK targets established, cash-generating U.S. businesses with annual revenue between $10 million and $2.5 billion, focusing on upper middle-market companies with EBITDA of $50 million to $150 million or more at investment. It explicitly avoids start-ups, turnarounds, and speculative business plans. Portfolio exits are pursued through over-the-counter loan sales, loan repayments, IPOs, mergers, sales, or recapitalizations.
- Floating-rate loan yields rise with elevated SOFR benchmark
- Non-accruals and credit losses pressure NAV as middle market weakens
- Private credit origination volumes accelerate through KKR partnership
| Net Income: -375.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 9.77 > 1.0 |
| NWC/Revenue: 35.55% < 20% (prev 71.41%; Δ -35.86% < -1%) |
| CFO/TA 0.13 > 3% & CFO 1.58b > Net Income -375.0m |
| Net Debt (7.53b) to EBITDA (175.0m): 43.01 < 3 |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (280.2m) vs 12m ago 0.06% < -2% |
| Gross Margin: 60.55% > 18% (prev 39.69%; Δ 20.86% > 0.5%) |
| Asset Turnover: 7.13% > 50% (prev 5.25%; Δ 1.88% > 0%) |
| Interest Coverage Ratio: -0.01 > 6 (EBIT TTM -3.00m / Interest Expense TTM 437.0m) |
| A: 0.03 (Total Current Assets 576.0m - Total Current Liabilities 239.0m) / Total Assets 12.0b |
| B: -0.34 (Retained Earnings -4.08b / Total Assets 12.0b) |
| C: -0.00 (EBIT TTM -3.00m / Avg Total Assets 13.3b) |
| D: 0.79 (Book Value of Equity 5.27b / Total Liabilities 6.71b) |
| Altman-Z'' = -0.10 = B |
As of August 22, 2026, the stock is trading at USD 11.91 with a total of 1,098,662 shares traded. Over the past week, the price has changed by -3.64%, over one month by +8.37%, over three months by +13.38% and over the past year by -19.92%.
Current recommended Stop Loss: 11.40 (which is 4.3% or 1.5 ATR below the current price).
FS KKR Capital has received a consensus analysts rating of 3.00. Therefore, it is recommended to hold FSK.
- StrongBuy: 1
- Buy: 0
- Hold: 8
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 11.9 | -0.1% |
P/E Forward = 7.6982
P/S = 2.5028
P/B = 0.6485
P/EG = 3.2724
Revenue TTM = 948.0m USD
EBIT TTM = -3.00m USD
EBITDA TTM = 175.0m USD
Long Term Debt = 7.63b USD (from longTermDebt, last fiscal year)
Short Term Debt = unknown (none)
Debt = 7.63b USD (corrected: LT Debt 7.63b + ST Debt none)
Net Debt = 7.53b USD (calculated: Debt 7.63b - CCE 107.0m)
Enterprise Value = 10.9b USD (3.33b + Debt 7.63b - CCE 107.0m)
Interest Coverage Ratio = -0.01 (Ebit TTM -3.00m / Interest Expense TTM 437.0m)
EV/FCF = 6.86x (Enterprise Value 10.9b / FCF TTM 1.58b)
FCF Yield = 14.57% (FCF TTM 1.58b / Enterprise Value 10.9b)
FCF Margin = 166.9% (FCF TTM 1.58b / Revenue TTM 948.0m)
Net Margin = -39.56% (Net Income TTM -375.0m / Revenue TTM 948.0m)
Gross Margin = 60.55% ((Revenue TTM 948.0m - Cost of Revenue TTM 374.0m) / Revenue TTM)
Gross Margin QoQ = 65.17% (prev 27.62%)
Tobins Q-Ratio = 0.91 (Enterprise Value 10.9b / Total Assets 12.0b)
Interest Expense / Debt = 5.72% (Interest Expense 437.0m / Debt 7.63b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -2.37m (EBIT -3.00m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.41 (Total Current Assets 576.0m / Total Current Liabilities 239.0m)
Debt / Equity = 1.45 (Debt 7.63b / totalStockholderEquity, last quarter 5.27b)
Debt / EBITDA = 43.01 (Net Debt 7.53b / EBITDA 175.0m)
Debt / FCF = 4.76 (Net Debt 7.53b / FCF TTM 1.58b)
Total Stockholder Equity = 5.64b (last 4 quarters mean from totalStockholderEquity)
RoA = -2.82% (Net Income -375.0m / Total Assets 12.0b)
RoE = -6.65% (Net Income TTM -375.0m / Total Stockholder Equity 5.64b)
RoCE = -0.02% (EBIT -3.00m / Capital Employed (Equity 5.64b + L.T.Debt 7.63b))
RoIC = -0.02% (negative operating profit) (NOPAT -2.37m / Invested Capital 11.7b)
WACC = 5.73% (E(3.33b)/V(11.0b) * Re(8.49%) + D(7.63b)/V(11.0b) * Rd(5.72%) * (1-Tc(0.21)))
Discount Rate = 8.49% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 52.50 | Cagr: 0.03%
[DCF] Terminal Value 77.97% ; FCFF base≈1.15b ; Y1≈1.32b ; Y5≈1.94b
[DCF] Fair Price = 78.31 (EV 29.2b - Net Debt 7.53b = Equity 21.6b / Shares 276.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -94.34 | EPS CAGR: -17.06% | SUE: 0.34 | # QB: 0
Revenue Correlation: -81.42 | Revenue CAGR: -19.00% | SUE: 0.01 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.41 | Chg30d=-3.10% | Revisions=-12% | Analysts=10
EPS current Year (2026-12-31): EPS=1.62 | Chg30d=-1.44% | Revisions=+29% | GrowthEPS=-30.8% | GrowthRev=-25.2%
EPS next Year (2027-12-31): EPS=1.51 | Chg30d=-1.89% | Revisions=+30% | GrowthEPS=-6.7% | GrowthRev=-5.1%
[Analyst] Revisions Ratio: +21% (up=10, down=6)